Identifying Disease Associated miRNAs Based on Protein Domains

MicroRNAs (miRNAs) are a class of small endogenous non-coding genes, acting as regulators in the post-transcriptional processes. Recently, the miRNAs are found to be widely involved in different types of diseases. Therefore, the identification of disease associated miRNAs can help understand the mechanisms that underlie the disease and identify new biomarkers. However, it is not easy to identify the miRNAs related to diseases due to its extensive involvements in various biological processes. In this work, we present a new approach to identify disease associated miRNAs based on domains, the functional and structural blocks of proteins. The results on real datasets demonstrate that our method can effectively identify disease related miRNAs with high precision.

[1]  Xing-Ming Zhao,et al.  Predicting drug targets based on protein domains. , 2012, Molecular bioSystems.

[2]  Lewis R. Roberts,et al.  Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.

[3]  Yufei Huang,et al.  Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.

[4]  Hailin Chen,et al.  Similarity-based methods for potential human microRNA-disease association prediction , 2013, BMC Medical Genomics.

[5]  Xantha Karp,et al.  Encountering MicroRNAs in Cell Fate Signaling , 2005, Science.

[6]  Yuan Wang,et al.  [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression]. , 2014, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[7]  R. Jiang,et al.  Prioritisation of associations between protein domains and complex diseases using domain-domain interaction networks. , 2010, IET systems biology.

[8]  Rongguo Li,et al.  Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway , 2015, OncoTargets and therapy.

[9]  Xiaodong Gu,et al.  miR-449b inhibits the proliferation of SW1116 colon cancer stem cells through downregulation of CCND1 and E2F3 expression. , 2013, Oncology reports.

[10]  Teresa M. Przytycka,et al.  DOMINE: a database of protein domain interactions , 2007, Nucleic Acids Res..

[11]  Xiao-Qian Zhao,et al.  Lack of Association of MiR-34b/c Polymorphism (rs4938723) with Hepatocellular Carcinoma: A Meta-Analysis , 2013, PloS one.

[12]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[13]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[14]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[15]  R. Xiang,et al.  BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer. , 2013, Biochimica et biophysica acta.

[16]  Cheng Wang,et al.  YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression , 2014, Oncogene.

[17]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[18]  L. Holm,et al.  The Pfam protein families database , 2005, Nucleic Acids Res..

[19]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[20]  Peter B. McGarvey,et al.  Infrastructure for the life sciences: design and implementation of the UniProt website , 2009, BMC Bioinformatics.

[21]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[22]  Yuanqing Ye,et al.  Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. , 2008, Cancer research.

[23]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[24]  R. Jiang.  Walking on multiple disease-gene networks to prioritize candidate genes. , 2015, Journal of molecular cell biology.

[25]  J. Aster,et al.  The double-edged sword of Notch signaling in cancer. , 2012, Seminars in cell & developmental biology.

[26]  Rui Jiang,et al.  Pinpointing disease genes through phenomic and genomic data fusion , 2015, BMC Genomics.

[27]  E. Miska,et al.  How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.

[28]  Xing-Ming Zhao,et al.  Identifying cancer-related microRNAs based on gene expression data , 2015, Bioinform..

[29]  Roded Sharan,et al.  Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..

[30]  Yu-mei Rao 饶玉梅,et al.  MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells , 2013, Journal of Huazhong University of Science and Technology [Medical Sciences].

[31]  A. Stegh.  Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils , 2012, Expert opinion on therapeutic targets.

[32]  D. Fishman,et al.  microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition , 2014, Nature Communications.

[33]  Udo Schumacher,et al.  Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds , 2013, Molecular Cancer.

[34]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[35]  Gonzalo Vicente,et al.  Expression of MicroRNA-15b and the Glycosyltransferase GCNT3 Correlates with Antitumor Efficacy of Rosemary Diterpenes in Colon and Pancreatic Cancer , 2014, PloS one.

[36]  Xu Ma,et al.  MiR‐185 is involved in human breast carcinogenesis by targeting Vegfa , 2014, FEBS letters.

[37]  K. Aihara,et al.  A discriminative approach for identifying domain–domain interactions from protein–protein interactions , 2010, Proteins.

[38]  Bing Shi,et al.  TAM: A method for enrichment and depletion analysis of a microRNA category in a list of microRNAs , 2010, BMC Bioinformatics.

[39]  Marta Hoffmann,et al.  Bisphenol A induce ovarian cancer cell migration via the MAPK and PI3K/Akt signalling pathways. , 2014, Toxicology letters.

[40]  Hsien-Da Huang,et al.  miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions , 2013, Nucleic Acids Res..

[41]  Christina Backes,et al.  GeneTrail—advanced gene set enrichment analysis , 2007, Nucleic Acids Res..

[42]  Ujjwal Maulik,et al.  Development of the human cancer microRNA network , 2010 .

[43]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[44]  Rui Jiang,et al.  Comparative study of network-based prioritization of protein domains associated with human complex diseases , 2010 .

[45]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[46]  Taichi Isobe,et al.  miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway , 2014, eLife.

[47]  C. Lindley,et al.  Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. , 2006, Clinical therapeutics.

[48]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[49]  L. Meng,et al.  miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1 , 2013, Oncology letters.

[50]  Zhaolei Zhang,et al.  Evidence for Positive Selection on a Number of MicroRNA Regulatory Interactions during Recent Human Evolution , 2012, PLoS genetics.